pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapySurface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis.Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
P2860
pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
pH-Responsive therapeutic soli ...... tidrug resistant cancer cells.
@ast
pH-Responsive therapeutic soli ...... tidrug resistant cancer cells.
@en
type
label
pH-Responsive therapeutic soli ...... tidrug resistant cancer cells.
@ast
pH-Responsive therapeutic soli ...... tidrug resistant cancer cells.
@en
prefLabel
pH-Responsive therapeutic soli ...... tidrug resistant cancer cells.
@ast
pH-Responsive therapeutic soli ...... tidrug resistant cancer cells.
@en
P2093
P2860
P356
P1476
pH-Responsive therapeutic soli ...... tidrug resistant cancer cells.
@en
P2093
Hsin-Hung Chen
Ming-Yin Shen
Sung-Chyr Lin
Wen-Chia Huang
Wen-Hsuan Chiang
Yuan-Hung Hsu
P2860
P304
P356
10.2147/IJN.S86053
P407
P577
2015-08-05T00:00:00Z